InvestorsHub Logo
Followers 53
Posts 1789
Boards Moderated 0
Alias Born 03/22/2015

Re: Chasing post# 308084

Thursday, 01/17/2019 11:00:05 PM

Thursday, January 17, 2019 11:00:05 PM

Post# of 404141
Purdue already said thanks but no thanks


proof of that?




http://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=75014&GoTopage=9&Category=2163&BzID=2258&t=1960&G=939

Aug 04, 2004
Elite Pharmaceuticals Announces Exclusive Option To License Its Technology Granted To Purdue Pharma Has Lapsed
Northvale, New Jersey, Wednesday, August 04, 2004: Elite Pharmaceuticals, Inc. (AMEX:ELI) today announced that the exclusive right to negotiate a license from Elite’s wholly owned subsidiary, Elite Laboratories, Inc., for Elite’s proprietary abuse resistance technology for oxycodone, previously granted to Purdue Pharma L.P., has lapsed. With the inaction of Purdue with respect to this option, the exclusivity granted to Purdue has terminated and Elite intends to recommence negotiations to license its proprietary abuse resistance technology to other companies.





Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News